At Dexcom (Nasdaq:DXCM), one of the leaders in continuous glucose monitoring (CGM), innovation continues to roll on.

Dexcom ONE+ is now available in the UK, incorporating 25 years of Dexcom research to offer a sensor that better meets the needs of those living with diabetes. Dexcom’s first-ever State of Type 2 ...

This week, Tandem Diabetes Care’s t:slim X2 insulin pump and Control-IQ algorithm made headlines as they became the first to integrate with Dexcom’s G7 sensor to create an artificial pancreas ...

With a new CEO taking over in 2026, Dexcom aims to stay ahead of its CGM competitors through a combination of innovation and product market expansion.

DexCom, Inc. DXCM announced that its DexCom ONE continuous glucose monitoring (CGM) system has been launched in France for people with diabetes. The latest CGM sensor from the company’s ...

Over the next few quarters, Dexcom could profit from the possibility to link Dexcom sensors with the Apple Watch.

Oppenheimer downgraded DexCom (DXCM) to Perform from Outperform without a price target after assuming coverage of the name. The company is doing ...

DexCom is handing over shares in itself to Google as part of a new blood glucose monitoring collaboration.

In the best of all worlds, the Dexcom sensor would work with all pumps, but that of course is asking for too much. Medical-device makers, their eye ever on the bottom line, want you to be monogamous.

DexCom, Inc., a global leader in real-time continuous glucose monitoring for people with diabetes, today announced both the launch of Dexcom ONE+, a CGM device that easily tracks real-time glucose ...